Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Biohaven Ltd. (BHVN) Balance Sheet

As of 2026-06-30 (10-Q), Biohaven Ltd. (BHVN) reported total assets of $370.7M, total liabilities of $358.5M and shareholders' equity of $12.2M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $238.0M. Long-term debt: $259.5M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BHVNBiohaven Ltd.Follow BHVN — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
2.1B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
17 Nov, in 24 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents204.9248.499.1230.0238.0
Short-term investments260.5133.4386.989.229.8
Current assets587.0442.4538.5368.3296.6
Total assets661.8513.2615.1451.4370.7
Current liabilities90.055.4154.2115.962.7
Long-term debt——0.0238.9259.5
Total liabilities123.085.2191.7399.4358.5
Shareholders' equity538.8428.0423.452.112.2

USD millions · SEC XBRL

Biohaven Ltd. — questions

How much cash does Biohaven Ltd. have?
$238.0M in cash and cash equivalents as of 2026-06-30.
How much debt does Biohaven Ltd. have?
$259.5M of long-term debt as of 2026-06-30.
What are Biohaven Ltd.'s total assets?
$370.7M as of 2026-06-30.
What is Biohaven Ltd.'s shareholders' equity?
$12.2M as of 2026-06-30.

Every figure on this page comes from Biohaven Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.